go to contents

a:head bio AG

Back to list

Facts

Founded
2019
Staff
9
Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health

Profile

a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids

R&D:a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement.

Similar companies in RDM biotech/pharma

Mark53 GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

BioNTech R&D (Austria) GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

AGRANA Research

Organization type
RDM biotech/pharma
Region
Lower Austria
Cluster
ecoplus
Focus
agricultural biotechnology
Details

Sigmapharm Arzneimittel GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Contact

Dr.-Bohr-Gasse 7, VBC6
1030 Wien
Vienna

Contact: Oliver Szolar (CEO)
Email: office@aheadbio.com
Website